Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2, indicating an updated document version.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a newer build of the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment is closed. New help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and the page revision label updated to v3.6.0.SummaryDifference0.4%

- Check31 days agoChange DetectedThe page now shows a new revision tag, v3.5.5, replacing the previous v3.5.4, indicating an updated build/deployment of the page.SummaryDifference0.0%

- Check45 days agoChange DetectedThere are no additions or deletions documented for this page; the content remains as previously listed.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the study detail page, signaling a minor platform/template update. The content and data shown for the study remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.